Skip to main content
Erschienen in: European Radiology 5/2021

30.10.2020 | Hepatobiliary-Pancreas

CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis

verfasst von: Sohee Park, Jong Keon Jang, Jae Ho Byun, Jin Hee Kim, Seung Soo Lee, Hyoung Jung Kim, Seung Baek Hong, Seong Ho Park

Erschienen in: European Radiology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We aimed to systematically evaluate the diagnostic accuracy of CT-determined resectability following neoadjuvant treatment for predicting margin-negative resection (R0 resection) in patients with pancreatic ductal adenocarcinoma (PDAC).

Methods

Original studies with sufficient details to obtain the sensitivity and specificity of CT-determined resectability following neoadjuvant treatment, with a reference on the pathological margin status, were identified in PubMed, EMBASE, and Cochrane databases until February 24, 2020. The identified studies were divided into two groups based on the criteria of R0 resectable tumor (ordinary criterion: resectable PDAC alone; extended criterion: resectable and borderline resectable PDAC). The meta-analytic summary of the sensitivity and specificity for each criterion was estimated separately using a bivariate random-effect model. Summary results of the two criteria were compared using a joint-model bivariate meta-regression.

Results

Of 739 studies initially searched, 6 studies (6 with ordinary criterion and 5 with extended criterion) were included for analysis. The meta-analytic summary of sensitivity and specificity was 45% (95% confidence interval [CI], 19–73%; I2 = 88.3%) and 85% (95% CI, 65–94%; I2 = 60.5%) for the ordinary criterion, and 81% (95% CI, 71–87%; I2 = 0.0%) and 42% (95% CI, 28–57%; I2 = 6.2%) for the extended criterion, respectively. The diagnostic accuracy significantly differed between the two criteria (p = 0.02).

Conclusions

For determining resectability on CT, the ordinary criterion might be highly specific but insensitive for predicting R0 resection, whereas the extended criterion increased sensitivity but would decrease specificity. Further investigations using quantitative parameters may improve the identification of R0 resection.

Key Points

CT-determined resectability of PDAC after neoadjuvant treatment using the ordinary criterion shows low sensitivity and high specificity in predicting R0 resection.
With the extended criterion, CT-determined resectability shows higher sensitivity but lower specificity than with the ordinary criterion.
CT-determined resectability with both criteria achieved suboptimal diagnostic performances, suggesting that care should be taken while selecting surgical candidates and when determining the surgical extent after neoadjuvant treatment in patients with PDAC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Ryan DP, Hong TS, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371:2140–2141CrossRef Ryan DP, Hong TS, Bardeesy N (2014) Pancreatic adenocarcinoma. N Engl J Med 371:2140–2141CrossRef
3.
Zurück zum Zitat Mercadante S, Tirelli W, David F et al (2010) Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain 26:794–797CrossRef Mercadante S, Tirelli W, David F et al (2010) Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain 26:794–797CrossRef
4.
Zurück zum Zitat Tempero MA, Malafa MP, Chiorean EG et al (2019) Pancreatic adenocarcinoma, version 1.2019. J Natl Compr Canc Netw 17:202–210CrossRef Tempero MA, Malafa MP, Chiorean EG et al (2019) Pancreatic adenocarcinoma, version 1.2019. J Natl Compr Canc Netw 17:202–210CrossRef
5.
Zurück zum Zitat Versteijne E, Vogel JA, Besselink MG et al (2018) Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 105:946–958CrossRef Versteijne E, Vogel JA, Besselink MG et al (2018) Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg 105:946–958CrossRef
6.
Zurück zum Zitat Suker M, Beumer BR, Sadot E et al (2016) FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol 17:801–810CrossRef Suker M, Beumer BR, Sadot E et al (2016) FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol 17:801–810CrossRef
7.
Zurück zum Zitat Somers I, Bipat S (2017) Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT. Eur Radiol 27:3408–3435CrossRef Somers I, Bipat S (2017) Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT. Eur Radiol 27:3408–3435CrossRef
8.
Zurück zum Zitat Kulkarni NM, Soloff EV, Tolat PP et al (2020) White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. Abdom Radiol (NY) 45:716–728CrossRef Kulkarni NM, Soloff EV, Tolat PP et al (2020) White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. Abdom Radiol (NY) 45:716–728CrossRef
9.
Zurück zum Zitat Pietryga JA, Morgan DE (2015) Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol 6:343–357PubMedPubMedCentral Pietryga JA, Morgan DE (2015) Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol 6:343–357PubMedPubMedCentral
10.
Zurück zum Zitat Cassinotto C, Mouries A, Lafourcade JP et al (2014) Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy. Radiology 273:108–116CrossRef Cassinotto C, Mouries A, Lafourcade JP et al (2014) Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy. Radiology 273:108–116CrossRef
11.
Zurück zum Zitat Cassinotto C, Cortade J, Belleannée G et al (2013) An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment. Eur J Radiol 82:589–593CrossRef Cassinotto C, Cortade J, Belleannée G et al (2013) An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment. Eur J Radiol 82:589–593CrossRef
13.
Zurück zum Zitat Kim BR, Kim JH, Ahn SJ et al (2019) CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis. Eur Radiol 29:362–372CrossRef Kim BR, Kim JH, Ahn SJ et al (2019) CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis. Eur Radiol 29:362–372CrossRef
14.
Zurück zum Zitat Wagner M, Antunes C, Pietrasz D et al (2017) CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma. Eur Radiol 27:3104–3116CrossRef Wagner M, Antunes C, Pietrasz D et al (2017) CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma. Eur Radiol 27:3104–3116CrossRef
15.
Zurück zum Zitat Marchegiani G, Todaro V, Boninsegna E et al (2018) Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection. Eur Radiol 28:4265–4273CrossRef Marchegiani G, Todaro V, Boninsegna E et al (2018) Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection. Eur Radiol 28:4265–4273CrossRef
16.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRef Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRef
17.
Zurück zum Zitat Kim KW, Lee J, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part I. general guidance and tips. Korean J Radiol 16:1175–1187CrossRef Kim KW, Lee J, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part I. general guidance and tips. Korean J Radiol 16:1175–1187CrossRef
18.
Zurück zum Zitat Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6:9CrossRef Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6:9CrossRef
19.
Zurück zum Zitat Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990CrossRef Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982–990CrossRef
20.
Zurück zum Zitat Leeflang MM, Deeks JJ, Rutjes AW, Reitsma JB, Bossuyt PM (2012) Bivariate meta-analysis of predictive values of diagnostic tests can be an alternative to bivariate meta-analysis of sensitivity and specificity. J Clin Epidemiol 65:1088–1097CrossRef Leeflang MM, Deeks JJ, Rutjes AW, Reitsma JB, Bossuyt PM (2012) Bivariate meta-analysis of predictive values of diagnostic tests can be an alternative to bivariate meta-analysis of sensitivity and specificity. J Clin Epidemiol 65:1088–1097CrossRef
21.
Zurück zum Zitat Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20:2865–2884CrossRef Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20:2865–2884CrossRef
22.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558CrossRef
23.
Zurück zum Zitat Deville WL, Buntinx F, Bouter LM et al (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9CrossRef Deville WL, Buntinx F, Bouter LM et al (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9CrossRef
24.
Zurück zum Zitat White RR, Paulson EK, Freed KS et al (2001) Staging of pancreatic cancer before and after neoadjuvant chemoradiation. J Gastrointest Surg 5:626–633CrossRef White RR, Paulson EK, Freed KS et al (2001) Staging of pancreatic cancer before and after neoadjuvant chemoradiation. J Gastrointest Surg 5:626–633CrossRef
25.
Zurück zum Zitat Kim YE, Park MS, Hong HS et al (2009) Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer. Radiology 250:758–765CrossRef Kim YE, Park MS, Hong HS et al (2009) Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer. Radiology 250:758–765CrossRef
26.
Zurück zum Zitat van Veldhuisen E, Walma MS, van Rijssen LB et al (2019) Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a prospective multicenter study. HPB (Oxford) 21:1385–1392CrossRef van Veldhuisen E, Walma MS, van Rijssen LB et al (2019) Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a prospective multicenter study. HPB (Oxford) 21:1385–1392CrossRef
27.
Zurück zum Zitat Joo I, Lee JM, Lee ES et al (2018) Preoperative MDCT assessment of resectability in borderline resectable pancreatic cancer: effect of neoadjuvant chemoradiation therapy. AJR Am J Roentgenol 210:1059–1065CrossRef Joo I, Lee JM, Lee ES et al (2018) Preoperative MDCT assessment of resectability in borderline resectable pancreatic cancer: effect of neoadjuvant chemoradiation therapy. AJR Am J Roentgenol 210:1059–1065CrossRef
28.
Zurück zum Zitat Joo I, Lee JM, Lee ES et al (2019) Preoperative CT classification of the resectability of pancreatic cancer: interobserver agreement. Radiology 293:343–349CrossRef Joo I, Lee JM, Lee ES et al (2019) Preoperative CT classification of the resectability of pancreatic cancer: interobserver agreement. Radiology 293:343–349CrossRef
29.
Zurück zum Zitat Klaiber U, Mihaljevic A, Hackert T (2019) Radical pancreatic cancer surgery-with arterial resection. Transl Gastroenterol Hepatol 4:8CrossRef Klaiber U, Mihaljevic A, Hackert T (2019) Radical pancreatic cancer surgery-with arterial resection. Transl Gastroenterol Hepatol 4:8CrossRef
30.
Zurück zum Zitat Kwon HJ, Kim SG (2012) Surgical treatment for advanced pancreatic cancer. Korean J Hepatobiliary Pancreat Surg 16:89–92CrossRef Kwon HJ, Kim SG (2012) Surgical treatment for advanced pancreatic cancer. Korean J Hepatobiliary Pancreat Surg 16:89–92CrossRef
31.
Zurück zum Zitat Chu LC, Park S, Kawamoto S et al (2019) Utility of CT radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue. AJR Am J Roentgenol 213:349–357CrossRef Chu LC, Park S, Kawamoto S et al (2019) Utility of CT radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue. AJR Am J Roentgenol 213:349–357CrossRef
32.
Zurück zum Zitat Liu K-L, Wu T, Chen P-T et al (2020) Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validation. Lancet Digital Health 2:e303–e313CrossRef Liu K-L, Wu T, Chen P-T et al (2020) Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validation. Lancet Digital Health 2:e303–e313CrossRef
33.
Zurück zum Zitat Bian Y, Jiang H, Ma C et al (2020) Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer. Abdom Radiol (NY) 45:759–773CrossRef Bian Y, Jiang H, Ma C et al (2020) Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer. Abdom Radiol (NY) 45:759–773CrossRef
36.
Zurück zum Zitat Suh CH, Jung SC, Kim KW, Pyo J (2016) The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis. J Neurooncol 129:363–371CrossRef Suh CH, Jung SC, Kim KW, Pyo J (2016) The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis. J Neurooncol 129:363–371CrossRef
Metadaten
Titel
CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis
verfasst von
Sohee Park
Jong Keon Jang
Jae Ho Byun
Jin Hee Kim
Seung Soo Lee
Hyoung Jung Kim
Seung Baek Hong
Seong Ho Park
Publikationsdatum
30.10.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2021
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07433-0

Weitere Artikel der Ausgabe 5/2021

European Radiology 5/2021 Zur Ausgabe

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.